Skip to content

Effect of lidocaine injection into endotracheal tube on incidence of cough and laryngospasm in patients candidating cataract surgery

A comparison between the effectiveness of 2% lidocaine injection into endotracheal tube and the normal method on the incidence of cough and laryngospasm in patients candidating cataract surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201406026808N5
Enrollment
96
Registered
2014-07-10
Start date
2012-12-15
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cataract. Senile incipient cataract

Interventions

Intervention 1: In test group: 100 mg (5ml) of lidocaine 2% was injected into endotracheal tube. Intervention 2: In control group (5ml) same volume of placebo (normal saline) was injected into endotr
Treatment - Drugs
Placebo
In test group: 100 mg (5ml) of lidocaine 2% was injected into endotracheal tube
In control group (5ml) same volume of placebo (normal saline) was injected into endotracheal tube

Sponsors

Birjand University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria : Candidate cataract surgery; class I and II based on the classification of the American Society of Anesthesiology Exclusion criteria : ?Chronic obstructive pulmonary disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Cough. Timepoint: In two states :after extubation at surgery room and recovery room. Method of measurement: without cough, moderate cough, including one to five coughs and severe cough, including more than five cough.

Secondary

MeasureTime frame
Laryngospasm. Timepoint: In two states:after extubation at surgery room and recovery room. Method of measurement: The presence of laryngospasm.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Tolyat

Birjand University of Medical Sciences

tolyatm@yahoo.com+98 56 1882 5450

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026